Protecting Your Pharmacy from DEA Risk and Distributor Cut-Off

The compliance landscape for independent pharmacies has changed—and it’s getting tougher.

Ongoing opioid litigation, enforcement actions, and increased scrutiny from the DEA have fundamentally reshaped regulatory compliance expectations across the independent pharmacy supply chain. In response, drug distributors and manufacturers are tightening controls and imposing requirements that often go well beyond baseline DEA regulations.

For independent pharmacies, this creates a dual risk:

• Regulatory risk from the DEA (audits, inspections, enforcement actions)
• Business risk from distributors (suspicious order holds, account restrictions, or termination)

Losing a distributor relationship can be operationally devastating—sometimes more immediately damaging and threatening to the bottom line than a regulatory action imposed by the DEA.

The good news: many of the same steps that prepare you for a DEA inspection also reduce your risk of being cut off by a distributor. The key is proactively addressing the “red flags” that both entities are watching.

Start with the Fundamentals: The Controlled Substance Lifecycle

At its core, DEA compliance is straightforward in principle: you must maintain complete accountability for controlled substances throughout their “lifecycle” from purchase to dispensing or disposal.

Both DEA diversion investigators and distributors evaluate your pharmacy through this lens. Their reviews typically include:

• Detailed record audits
• Suspicious order analysis
• Physical security inspections
• Staff interviews and knowledge checks
• Evaluation of prescribing and dispensing patterns
• Ensuring strong “Know Your Customer” (KYC) practices

They are looking for one thing above all: consistency, completeness, and control.

How well would you do on these factors if an inspection happened today? Ask yourself:

• Are all controlled substances in stock accurately tracked, inventoried, and dispensed?
• Is physical and procedural security – from alarms, to cameras, to standard operating policies - strong enough to prevent diversion?
• Is all required documentation complete, accurate, and easily retrievable?
• Can staff clearly explain and demonstrate compliant processes? Are they trained as well as they should be?

A Practical, 360-Degree Compliance Review

Here’s the positive news: the steps you’ll take to tighten your operations will produce benefits for both DEA and distributor scrutiny, improving your odds of avoiding costly penalties and disastrous contract disruptions.

1. Conduct a Rigorous Records Review: Your documentation is your first line of defense.

Be sure that you regularly:

• Verify inventory accuracy across all schedules
• Ensure Schedule II records are properly separated from Schedule III–V
• Reconcile invoices, receipts, dispensing logs, and disposal records
• Investigate and resolve any discrepancies immediately
• Confirm that all required records are complete, accurate and easily accessible.

2. Tighten Physical and Operational Security: Security is not about convenience—it’s about control. When was the last time you:

• Confirmed all cameras, alarms, and monitoring systems were functioning properly?
• Check that you’ve limited access to controlled substances to essential personnel only?
• Ensure that all keys, alarm codes, and safe combinations were secured?
• Validated employee screenings (e.g., updated background checks, conducted drug screenings)?

3. Ensure Staff Competency and Accountability: Compliance is not just about policies and procedures – it’s a consistent focus on learned behaviors. Staff must:

• Understand DEA requirements and internal practices and procedures that fulfill those requirements.
• Follow KYC protocols consistently
• Recognize red flags in prescriptions and patient behavior
• Understand that you have a “zero tolerance” environment when it comes to skipping or violating the systems you put in place related to controlled substances.

4. Close the Loop on Prior Findings: If you’ve been cited before by the DEA, a distributor, or a state board, you’re under higher scrutiny. Ensure all corrective actions have been implemented and documented. Failing to make or ignoring required changes that you were notified about is, in many ways, worse than being accidentally out of compliance. You’re now facing even harsher penalties.

5. Address Prescriber and Patient Risk: Are you and your staff watching for patterns such as:

• Practitioners prescribing high-risk drug combinations (such as benzos mixed with narcotics)
• Cash-only transactions
• Patients traveling long distances to see prescribers and fill prescriptions only at your store
• Multiple patients from the same address getting the same or very similar prescriptions from the same practitioner.

These are high-visibility red flags. Ignoring them puts your business at risk. Get them out of your customer base - NOW.

6. Monitor High MME Exposure: Evaluate whether high-dose prescriptions are clinically justified and supported by documentation. Keep meticulous records.

7. Manage Suspicious Orders Proactively: Whether done on purpose or by mistake, suspicious orders (e.g., unusually larger orders, unusual ordering patterns) may mean those orders are frozen and not fulfilled – or could result in a distributor probe that ends in your account being closed.

• Investigate flagged orders immediately
• Communicate with your distributor
• Document resolution steps

8. Understand the Impact of Regulatory Actions: Any disciplinary action—DEA or state board—affects how distributors view your risk profile. Get the problems resolved – and document the steps taken to get there.

Where Independent Pharmacies Are Most Vulnerable

Independent pharmacies often have fewer resources, rely on limited distributors, and operate with lean staffing. These factors increase risk if not managed proactively.

But TITAN Group is your secret weapon for keeping your business operating, even in the face of greater scrutiny. TITAN Group provides:

• Compliance assessments and remediation planning
• Security and operational improvements
• Advanced recordkeeping systems
• Staff training and audit preparation
• Distributor relationship support and issues remediation

With a strong national track record of helping independent pharmacies preserve distributor relationships and survive DEA scrutiny, TITAN provides operational stability.

The pharmacies that succeed in this environment are proactive—not reactive. If you’re unsure where you stand, now is the time to find out. Contact TITAN Group today to learn more about how we can support your success.